These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9353347)
1. Selective inhibition of mitogen-induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV-1 transcriptional activation. Yasui H; Butscher W; Cohen M; Spriggs N; Wersto R; Kohn EC; Liotta L; Gardner K J Biol Chem; 1997 Nov; 272(45):28762-70. PubMed ID: 9353347 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
3. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region. Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412 [TBL] [Abstract][Full Text] [Related]
4. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
6. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. Cheng H; Tarnok J; Parks WP J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds. Lee R; Beauparlant P; Elford H; Ponka P; Hiscott J Virology; 1997 Aug; 234(2):277-90. PubMed ID: 9268159 [TBL] [Abstract][Full Text] [Related]
10. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Doerre S; Sista P; Sun SC; Ballard DW; Greene WC Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069 [TBL] [Abstract][Full Text] [Related]
11. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons. Miller SC; Taylor A; Watanabe K; Mok K; Torti FM Exp Cell Res; 1997 Jan; 230(1):9-21. PubMed ID: 9013701 [TBL] [Abstract][Full Text] [Related]
12. N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-kappaB DNA binding activity. Nottet HS; Moelans II; de Vos NM; de Graaf L; Visser MR; Verhoef J J Leukoc Biol; 1997 Jan; 61(1):33-9. PubMed ID: 9000534 [TBL] [Abstract][Full Text] [Related]
13. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. Zhang HS; Ruan Z; Sang WW J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388 [TBL] [Abstract][Full Text] [Related]
14. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. Zeichner SL; Kim JY; Alwine JC J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766 [TBL] [Abstract][Full Text] [Related]
15. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Li YC; Ross J; Scheppler JA; Franza BR Mol Cell Biol; 1991 Apr; 11(4):1883-93. PubMed ID: 2005886 [TBL] [Abstract][Full Text] [Related]
16. Regulation of HIV-1 gene expression by NF-IL6. Tesmer VM; Bina M J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998 [TBL] [Abstract][Full Text] [Related]
17. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. Doppler C; Schalasta G; Amtmann E; Sauer G AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410 [TBL] [Abstract][Full Text] [Related]
19. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903 [TBL] [Abstract][Full Text] [Related]
20. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B; De Luca P; Hagen G; Suske G; Lania L Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]